Literature DB >> 20696874

High-resolution crystal structure of the subclass B3 metallo-beta-lactamase BJP-1: rational basis for substrate specificity and interaction with sulfonamides.

Jean-Denis Docquier1, Manuela Benvenuti, Vito Calderone, Magdalena Stoczko, Nicola Menciassi, Gian Maria Rossolini, Stefano Mangani.   

Abstract

Metallo-β-lactamases (MBLs) are important enzymatic factors in resistance to β-lactam antibiotics that show important structural and functional heterogeneity. BJP-1 is a subclass B3 MBL determinant produced by Bradyrhizobium japonicum that exhibits interesting properties. BJP-1, like CAU-1 of Caulobacter vibrioides, overall poorly recognizes β-lactam substrates and shows an unusual substrate profile compared to other MBLs. In order to understand the structural basis of these properties, the crystal structure of BJP-1 was obtained at 1.4-Å resolution. This revealed significant differences in the conformation and locations of the active-site loops, determining a rather narrow active site and the presence of a unique N-terminal helix bearing Phe-31, whose side chain binds in the active site and represents an obstacle for β-lactam substrate binding. In order to probe the potential of sulfonamides (known to inhibit various zinc-dependent enzymes) to bind in the active sites of MBLs, the structure of BJP-1 in complex with 4-nitrobenzenesulfonamide was also obtained (at 1.33-A resolution), thereby revealing the mode of interaction of these molecules in MBLs. Interestingly, sulfonamide binding resulted in the displacement of the side chain of Phe-31 from its hydrophobic binding pocket, where the benzene ring of the molecule is now found. These data further highlight the structural diversity shown by MBLs but also provide interesting insights in the structure-function relationships of these enzymes. More importantly, we provided the first structural observation of MBL interaction with sulfonamides, which might represent an interesting scaffold for the design of MBL inhibitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696874      PMCID: PMC2944595          DOI: 10.1128/AAC.00409-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  50 in total

1.  Standard numbering scheme for class B beta-lactamases.

Authors:  M Galleni; J Lamotte-Brasseur; G M Rossolini; J Spencer; O Dideberg; J M Frère
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Expansion of the zinc metallo-hydrolase family of the beta-lactamase fold.

Authors:  H Daiyasu; K Osaka; Y Ishino; H Toh
Journal:  FEBS Lett       Date:  2001-08-10       Impact factor: 4.124

3.  Metallo-beta-lactamase producers in environmental microbiota: new molecular class B enzyme in Janthinobacterium lividum.

Authors:  G M Rossolini; M A Condemi; F Pantanella; J D Docquier; G Amicosante; M C Thaller
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

4.  CAU-1, a subclass B3 metallo-beta-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosome.

Authors:  Jean-Denis Docquier; Fabrizio Pantanella; Francesco Giuliani; Maria Cristina Thaller; Gianfranco Amicosante; Moreno Galleni; Jean-Marie Frère; Karen Bush; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme.

Authors:  S Chakravarty; K K Kannan
Journal:  J Mol Biol       Date:  1994-10-21       Impact factor: 5.469

6.  Common mechanistic features among metallo-beta-lactamases: a computational study of Aeromonas hydrophila CphA enzyme.

Authors:  Fabio Simona; Alessandra Magistrato; Matteo Dal Peraro; Andrea Cavalli; Alejandro J Vila; Paolo Carloni
Journal:  J Biol Chem       Date:  2009-08-11       Impact factor: 5.157

7.  Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX.

Authors:  Vincenzo Alterio; Mika Hilvo; Anna Di Fiore; Claudiu T Supuran; Peiwen Pan; Seppo Parkkila; Andrea Scaloni; Jaromir Pastorek; Silvia Pastorekova; Carlo Pedone; Andrea Scozzafava; Simona Maria Monti; Giuseppina De Simone
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-14       Impact factor: 11.205

Review 8.  The integration of macromolecular diffraction data.

Authors:  Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

9.  Antibiotic recognition by binuclear metallo-beta-lactamases revealed by X-ray crystallography.

Authors:  James Spencer; Jonathan Read; Richard B Sessions; Steven Howell; G Michael Blackburn; Steven J Gamblin
Journal:  J Am Chem Soc       Date:  2005-10-19       Impact factor: 15.419

10.  The 3-D structure of a zinc metallo-beta-lactamase from Bacillus cereus reveals a new type of protein fold.

Authors:  A Carfi; S Pares; E Duée; M Galleni; C Duez; J M Frère; O Dideberg
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

View more
  27 in total

1.  Crystal structure of the mobile metallo-β-lactamase AIM-1 from Pseudomonas aeruginosa: insights into antibiotic binding and the role of Gln157.

Authors:  Hanna-Kirsti S Leiros; Pardha S Borra; Bjørn Olav Brandsdal; Kine Susann Waade Edvardsen; James Spencer; Timothy R Walsh; Orjan Samuelsen
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Crystallization and preliminary X-ray analysis of the subclass B3 metallo-β-lactamase SMB-1 that confers carbapenem resistance.

Authors:  Jun-ichi Wachino; Yoshihiro Yamaguchi; Shigetarou Mori; Yuriko Yamagata; Yoshichika Arakawa; Keigo Shibayama
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-02-23

3.  A Systematic Approach to the Selection of the Appropriate Avibactam Concentration for Use with Ceftazidime in Broth Microdilution Susceptibility Testing.

Authors:  Patricia A Bradford; Michael D Huband; Gregory G Stone
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

4.  Structural Insights into Recognition of Hydrolyzed Carbapenems and Inhibitors by Subclass B3 Metallo-β-Lactamase SMB-1.

Authors:  Jun-Ichi Wachino; Yoshihiro Yamaguchi; Shigetarou Mori; Wanchun Jin; Kouji Kimura; Hiromasa Kurosaki; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

Review 5.  A close look onto structural models and primary ligands of metallo-β-lactamases.

Authors:  Joanna E Raczynska; Ivan G Shabalin; Wladek Minor; Alexander Wlodawer; Mariusz Jaskolski
Journal:  Drug Resist Updat       Date:  2018-08-25       Impact factor: 18.500

Review 6.  Fragment-based inhibitor discovery against β-lactamase.

Authors:  Derek A Nichols; Adam R Renslo; Yu Chen
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

Review 7.  Overcoming differences: The catalytic mechanism of metallo-β-lactamases.

Authors:  María-Rocío Meini; Leticia I Llarrull; Alejandro J Vila
Journal:  FEBS Lett       Date:  2015-08-20       Impact factor: 4.124

8.  Evolutionary insights into the active-site structures of the metallo-β-lactamase superfamily from a classification study with support vector machine.

Authors:  Lili Wang; Ling Yang; Yu-Lan Feng; Hao Zhang
Journal:  J Biol Inorg Chem       Date:  2020-09-18       Impact factor: 3.358

9.  Structural insights into the subclass B3 metallo-β-lactamase SMB-1 and the mode of inhibition by the common metallo-β-lactamase inhibitor mercaptoacetate.

Authors:  Jun-Ichi Wachino; Yoshihiro Yamaguchi; Shigetarou Mori; Hiromasa Kurosaki; Yoshichika Arakawa; Keigo Shibayama
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

10.  Crystal Structure of the Metallo-β-Lactamase GOB in the Periplasmic Dizinc Form Reveals an Unusual Metal Site.

Authors:  Jorgelina Morán-Barrio; María-Natalia Lisa; Nicole Larrieux; Salvador I Drusin; Alejandro M Viale; Diego M Moreno; Alejandro Buschiazzo; Alejandro J Vila
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.